Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial
about
sameAs
Triflusal for preventing serious vascular events in people at high riskThe Effects of Chunghyul-Dan (A Korean Medicine Herbal Complex) on Cardiovascular and Cerebrovascular Diseases: A Narrative ReviewLong-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-AnalysisAntiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysisReview of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agentsUpper gastrointestinal bleeding associated with antiplatelet drugsTriflusal: an antiplatelet drug with a neuroprotective effect?Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial.Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study.Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review.Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques.Stroke prevention: managing modifiable risk factors.Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology.A critical review of aspirin in the secondary prevention of noncardioembolic ischaemic stroke.Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 GenotypingStroke: secondary prevention.Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers.
P2860
Q24246399-DA89CE3D-D64E-41B5-BEDC-EFA6372AE641Q26747311-C04CA08B-E984-4206-9878-8B02ABC27645Q26797510-B8B8FF75-450E-4076-9745-63DF00AAA901Q28076042-C5B6F8A4-A794-4261-A330-5B9B140966BAQ28192470-8AE20E75-CAA7-44FB-8A41-EA759769CCDFQ28194354-17C3DDDB-778C-44E3-9099-2AB5839E4CC9Q28200341-C076DB22-D3D6-4750-809D-D5A89217DA5DQ30661716-5BA645EC-6649-42D4-9734-005273A4EDE4Q30881628-D67DDA5A-4BE7-40F3-B40D-3395E0B2E855Q33390176-D349FE04-851B-466A-A83F-65E13BC0BD9FQ33709834-ABACB0A2-368F-4946-BB38-DC462A76A0A9Q36130976-EE8CED85-824B-42AE-8A95-8473CDDE22DEQ36418118-EA7F8B66-A926-462A-929D-B7E33FFC1B93Q37362773-2342448C-6BCE-4148-A6B9-E332A1D0C8BEQ37623214-B701A166-6B47-40CE-A278-17A23F1D3BDAQ37773416-62AE5679-D392-463C-BB5A-81CD21BC4341Q38018679-5E16EA2B-D765-4C34-8DD3-A716FBE8B702Q40023249-CD7F623A-1CC5-4140-B4A4-4A95E7221905Q40110995-BD60B79A-DF43-4EA0-BC27-B0023360119CQ42380287-CADC24A1-01BB-437A-A54C-282FAC65B784Q46722175-521E8164-F9DE-4C2B-AEAF-F7DE202B959FQ51602399-17BC5E96-7A95-4915-BDFC-980723E94A4AQ53398086-1A12FC03-6E73-4FEA-A955-94E994630967
P2860
Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@ast
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@en
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@nl
type
label
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@ast
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@en
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@nl
prefLabel
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@ast
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@en
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@nl
P2093
P50
P921
P3181
P1433
P1476
Comparison of triflusal and as ...... ouble-blind, multicenter trial
@en
P2093
Jordi Matías-Guiu
M Dolores Jiménez
Teresa Melo
P3181
P356
10.1161/01.STR.0000063141.24491.50
P407
P577
2003-04-01T00:00:00Z